Aclaris Therapeutics, Inc. (ACRS)
NASDAQ: ACRS · Real-Time Price · USD
4.360
0.00 (0.00%)
At close: Jun 8, 2026, 4:00 PM EDT
4.360
0.00 (0.00%)
After-hours: Jun 8, 2026, 4:10 PM EDT
Aclaris Therapeutics Market Cap
Aclaris Therapeutics has a market cap or net worth of $608.93 million as of June 8, 2026. Its market cap has increased by 335.94% in one year.
Market Cap
608.93M
Enterprise Value
420.13M
1-Year Change
335.94%
Ranking
Category
Stock Price
$4.36
Market Cap Chart
Since October 7, 2015, Aclaris Therapeutics's market cap has increased from $214.45M to $608.93M, an increase of 183.95%. That is a compound annual growth rate of 10.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 608.93M | 86.72% |
| Dec 31, 2025 | 326.12M | 22.88% |
| Dec 31, 2024 | 265.41M | 256.83% |
| Dec 29, 2023 | 74.38M | -92.92% |
| Dec 30, 2022 | 1.05B | 17.97% |
| Dec 31, 2021 | 890.25M | 220.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Allogene Therapeutics | 648.89M |
| Alto Neuroscience | 640.06M |
| Tenax Therapeutics | 631.76M |
| SpyGlass Pharma | 627.75M |
| Zevra Therapeutics | 627.21M |
| BridgeBio Oncology Therapeutics | 625.64M |
| Relmada Therapeutics | 624.10M |
| Candel Therapeutics | 623.53M |